87407-53-2

Upstream product

• 87407-51-0 C₂₈H₄₈O₂Si 
• 228113-80-2 C₂₈H₄₈O₂Si 
• 50-14-6 Calciferol 
• 104846-62-0 3(S)-tert-butyldimethylsilyloxy-9,10-secoergosta-5,7(E),10⁽¹⁹⁾,22(E)-tetraene 
• 141411-00-9 (20S)-Des-A,B-22-(acetoxy)-23,24-dinorcholane-8-one 
• 99518-39-5 3β-hydroxy-22,23-dinor-5,7-choladienic acid methyl ester 
• 97903-24-7 (5Z,7E)-(3S,20S)-3-hydroxy-9,10-seco-5,7,10⁽¹⁹⁾pregnatriene-20-carboxylic acid methyl ester 
• 69454-87-1 (3β,20S)-3-<(tert-butyldimethylsilyl)oxy>pregn-5-ene-20-carboxylic acidmethyl ester 

Downstream Products

• 1258066-55-5 AB₄₇ 

Relevant academic research and scientific papers

22-HALOACETOXY-HOMOPREGNACALCIFEROL ANALOGS AND THEIR USES

This invention discloses 22-haloacetoxy-homopregnacalciferol analogs and specifically 22-bromoacetoxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits relatively little calcemic activity and does not promote cellular different

Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway

A structure-activity relationship study to elucidate the structural basis for hedgehog (Hh) signaling inhibition by vitamin D3 (VD3) was performed. Functional and non-functional regions of VD3 and VD2 were obtained through straightforward synthetic means